NewsDialy
Gathering investor claims is the first step toward a securities class-action lawsuit, a legal action in which a large group of shareholders collectively alleges that a company's conduct or its public disclosures caused their stock to lose value.
Pomerantz LLP, a New York plaintiffs firm, announced on July 16, 2026 that it is taking that step against AstraZeneca PLC (NYSE: AZN).
What an inquiry at this stage actually involves A securities investigation at this point is a structured intake process.
The firm is soliciting contact from investors who believe they suffered losses, reviewing what they describe, and building a record to evaluate whether a formal case is worth filing.
Keep reading